Skip to main content
Portfolio
TrendingElectionsPoliticsSportsCultureCryptoCommoditiesClimateEconomicsMentions

Finance

Tech & Science
PredictLive149AccountSocial
MARKETSINVESTLIVE149

Industries

Product
Kalshi ProInvestMarketsIncentive programSmall business hedgingInstitutionsAPI & developers
Company
AboutKalshi ResearchBlogCareersPolicy CenterBrand Kit
Help
Help CenterFAQPrediction marketsFee scheduleTrading hoursRegulatoryTrust Center

© 2026 Kalshi Inc. · All rights reserved
PrivacyData Terms of ServiceTrading ProhibitionsFAQ for Finance Professionals
Trading on Kalshi involves risk and may not be appropriate for all. Members risk losing their cost to enter any transaction, including fees. You should carefully consider whether trading on Kalshi is appropriate for you in light of your investment experience and financial resources. Any trading decisions you make are solely your responsibility and at your own risk. Information is provided for convenience only on an "AS IS" basis. Past performance is not necessarily indicative of future results. Kalshi is subject to U.S. regulatory oversight by the CFTC.
All markets (741)
15 min (10)
Hourly (8)
Daily (11)
Weekly (2)
Monthly (53)
Annual (20)

Public Companies Hub
Indices
Foreign Exchange
Interest Rates
Company metrics
Company news
Industries
Biotech
Advertising Spend
Real Estate
Sector Trends
Technology
Match Ups
Black Friday

Financials odds and guides

IPO odds for every companyStock market predictions: S&P 500 and Nasdaq-100

Austin, TX home values in November

Above $518,000
1.76x
Above $521,000
6.29x
$7,559 vol

Jersey City, NJ home values in November

Above $667,000
2.24x
Above $664,000
1.48x
$5,852 vol

Dallas, TX home values in November

Above $316,000
1.70x
Above $319,000
7.25x
$5,009 vol

San Diego, CA home values in November

Above $1,125,000
1.93x
Above $1,122,500
1.60x
$5,400 vol

Chicago, IL home values in November

Above $330,000
1.46x
Above $333,750
5.25x
$9,498 vol

Los Angeles, CA home values in November

Above $1,002,500
1.83x
Above $997,500
1.23x
$7,250 vol

Seattle, WA home values in November

Above $882,500
2.98x
Above $890,000
5.90x
$12,180 vol

Santa Monica, CA home values in November

Above $2.72 million
2.05x
Above $2.7 million
1.31x
$4,173 vol

New York, NY home values in November

Above $875,000
1.83x
Above $877,500
2.52x
$1,876 vol

Miami, FL home values in November

Above $670,000
1.73x
Above $667,500
1.26x
$4,466 vol

Venice, CA home values in November

Above $2,055,000
1.42x
Above $2.08 million
3.52x
$4,456 vol

FDA decision: Vamikibart by Genentech (on or before July 31, 2027)

Yes
1.44x
No
2.40x
$42 vol

FDA decision: Ulixacaltamide by Praxis Precision Medicines (on or before January 29, 2027)

Yes
1.28x
No
3.08x
$12 vol

FDA decision: Tozorakimab by AstraZeneca (on or before March 31, 2027)

Yes
1.16x
No
4.13x
$434 vol

FDA decision: Saroglitazar by Zydus Therapeutics (this year)

Yes
1.25x
No
3.40x
$1,842 vol

FDA decision: Ralinepag by United Therapeutics (on or before June 24, 2027)

Yes
1.19x
No
3.96x
$41 vol

Phoenix, AZ home values in November

Above $412,000
2.09x
Above $411,000
1.52x
$6,536 vol

Philadelphia, PA home values in November

Above $223,250
1.62x
Above $224,750
5.25x
$4,159 vol

Palo Alto, CA home values in November

Above $3.95 million
2.46x
Above $3.91 million
1.38x
$8,622 vol

Pacific Palisades, CA home values in November

Above $3.36 million
1.73x
Above $3.37 million
2.19x
$7,243 vol

Memphis, TN home values in December

Above $150,000
1.65x
Above $152,000
3.96x
$943 vol

FDA decision: Lorundrostat by Mineralys Therapeutics (on or before December 22, 2026)

Yes
1.14x
No
4.73x
$75 vol

Houston, TX condo values in February 2027

Below $124,000
2.14x
Below $127,000
1.26x
$0 vol

Hoboken, NJ home values in November

Above $1,280,000
1.83x
Above $1,270,000
1.36x
$5,522 vol